ikr6eeov | Knowledge4COVID-19

Property	Value
?:abstract	Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.
?:creator	<https://research.tib.eu/covid-19/entity/Perinel%2C_Sophie%3B_Launay%2C_Manon%3B_Botelho-Nevers%2C_%C3%89lisabeth%3B_Diconne%2C_%C3%89ric%3B_Louf-Durier%2C_Aurore%3B_Lachand%2C_Rapha%C3%ABl%3B_Murgier%2C_Martin%3B_Page%2C_Dominique%3B_Vermesch%2C_R%C3%A9gine%3B_Thierry%2C_Guillaume%3B_Delavenne%2C_Xavier>
?:doi	<https://research.tib.eu/covid-19/entity/10.1093/cid/ciaa394>
?:doi	10.1093/cid/ciaa394
?:journal	Clin_Infect_Dis
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/de0fd7d47650a5408b1577b60b73baeb2b92f2e0.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7184449>
?:pmid	<https://research.tib.eu/covid-19/entity/32255489.0>
?:pmid	32255489.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/de0fd7d47650a5408b1577b60b73baeb2b92f2e0>
?:source	Medline; PMC
?:title	Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-04-07

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/ikr6eeov>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/ikr6eeov>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all